CABA vs COIN · $143.9M cap vs P/E 64, rev $7.18B
Cabaletta Bio Inc (CABA) versus Coinbase Global Inc (COIN) — a side-by-side from cached financials, not a winner call.
Cabaletta Bio Inc (CABA) is a biotechnology company listed on US.
Coinbase Global Inc (COIN) is a financial data & stock exchanges company listed on US. It is led by Brian Armstrong.
CABA does not have a complete income-statement cache yet.
Latest reported COIN revenue for 2025-12-31 was $7.18B. Net income was $1.26B. Revenue was up 9.4% from 2024-12-31 to 2025-12-31. COIN currently screens at market cap $45.84B and trailing P/E 64.2.
CABA currently screens at market cap $143.9M. COIN currently screens at market cap $45.84B and trailing P/E 64.2.
Not investment advice. Open the CABA and COIN stock pages for the full models.
Not investment advice.